Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy
NCT04283539
·
clinicaltrials.gov ↗
UNKNOWN
Status
238
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DRUG:
systemic corticosteroid or biologic
Sponsor
National Jewish Health
Collaborators
[object Object]